Ylanan, Berlita .

HRN: 26-88-20  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/10/2026
CEFUROXIME 500MG (TAB)
01/10/2026
01/17/2026
PO
500
Q12
Uti
Checking Initial Appropriateness 

 Indication:  ProphylaxisEmpiric    Type of Infection:  Reproductive Tract    Compliance to guidelines: Compliant To Guidelines